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Nacre seashell is a natural osteoinductive biomaterial with 
strong effects on osteoprogenitors, osteoblasts, and osteo-
clasts during bone tissue formation and morphogenesis. 
Although nacre has shown, in one study, to induce bridg-
ing of new bone across large non-union bone defects in 8 
individual human patients, there have been no succeeding 
human surgical studies to confirm this outstanding poten-
cy. But the molecular mechanisms associated with nacre 
osteoinduction and the influence on bone marrow-derived 
mesenchymal stem cells (BMSC’s), skeletal stem cells or 
bone marrow stromal cells remain elusive. In this study we 
highlight the phenotypic and biochemical effects of 
Pinctada maxima nacre chips and the global nacre soluble 
protein matrix (SPM) on primary human bone marrow-
derived stromal cells (hBMSCs) in vitro. In static co-culture 
with nacre chips, the hBMSCs secreted Alkaline phospha-
tase (ALP) at levels that exceeded bone morphogenetic 
protein (rhBMP-2) treatment. Concentrated preparation of 
SPM applied to Stro-1 selected hBMSC’s led to rapid ALP 
secretions, at concentrations exceeding the untreated con-
trols even in osteogenic conditions. Within 21 days the 
same population of Stro-1 selected hBMSCs proliferated 
and secreted collagens I-IV, indicating the premature onset 
of an osteoblast phenotype. The same SPM was found to 
promote unselected hBMSC differentiation with osteocalcin 
detected at 7 days, and proliferation increased at 7 days in a 
dose-dependent manner. In conclusion, nacre particles and 
nacre SPM induced the early stages of human bone cell 
differentiation, indicating that they may be promising solu-
ble factors with osteoinductive capacity in primary human 
bone cell progenitors such as, hBMSC’s. 
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INTRODUCTION 
 
In an in vivo ectopic bone environment, a number of marine 
structures have shown osteoinductivity. This process involves 
the triggering of latent progenitors and pre-existing resident 
osteoblasts to conceive new bone from the beginning, de novo. 
Although there are many thousands of types of nacre seashell 
from different marine molluscs, pearl oyster (Pinctada maxima) 
nacre is the only species so far tested and validated for 
osteoinduction. Pearl oyster nacre is able to induce osteogenesis 
and bone formation from latent osteoprogenitors along an 
endochondral pathway, consisting of a cartilage tissue intermediary 
phase (Lamghari et al., 2001a; 2001b; Lopez et al., 1992; 
2004a; 2004b; Milet et al., 2004; Shen et al., 2006; Silve et al., 
1992). Nacre has been tested in human, sheep and rabbit 
models (Lamghari et al., 1999; 2001b; Liao et al., 2002). In 
human patients with critical size, non-union bone defects, fresh 
woven bone welded itself throughout the nacre implant with 
participation of osteoclasts and osteoblasts. It is important to 
have this cell partnership for continued bone health via 
remodeling. While nacre is stably tolerated in vivo, its degradation 
and resorption is limited and this could hinder its use within 
calcified tissue that requires rapid self-renewal (Lamghari et al., 
2001a; 2001b). Naturally, this has steered the exploitation of 
nacre towards the true source of nacre osteoinductivity- the 
water-soluble organic matrix (WSM) fraction (Duplat et al., 2007; 
Rousseau et al., 2003). In this article we use the term nacre 
soluble protein matrix (SPM) in place of the established term 
(WSM) as it more accurately describes the entire protein extract 
that is removed from nacre seashell and used to influence 
hBMSC activities. 
The SPM (acidic-rich particularly aspartic acid) participates in 
the control and regulation of crystallization and is an important 
stimulus on cell activities and intracellular molecular cascades 
associated with matrix mineralization. The strongest indications 
are that mobile peptides are released from the WSM when 
nacre is stripped from the shell and immersed in culture media 
or physiological fluids. The function of these mobile peptides 
mirrors that of transforming growth factor-beta (TGF-β) due to 
the correspondence in cell differentiation and proliferation 
timing profiles between bone marrow stromal cells (BMSCs) 
cultured with nacre and bone morphogenetic protein (BMP) and 
TGF-β-induced bone formation (Rousseau et al., 2003). 
Decalcification of the calcium carbonate platelets and 
extraction of the WSM yields four identifiable fractions (Bédouet 
et al., 2006). Peptides are prevalent in the nacre matrix (Bédouet 
et al., 2007). Particular individual fractions have been shown to 
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give rise to specific responses from cultured osteoblast cells. 
Protein fractions with low molecular weight (less than 1 kDa), for 
example, up-regulated alkaline phosphatase (ALP) secretion 
whereas high molecular weight fraction reduced ALP secretion. 
Low molecular weight (LMW) fractions were recently found to 
increase gene expression of collagen type I, osteopontin, and 
Runx2 (Rousseau et al., 2008; Wang et al., 2007). Further 
detailed characterization of the bioactive LMW molecules has 
led to the identification of 110 molecules in the 100-700 Da 
range comprising of glycine-enriched peptides with structural 
similarities and high affinities for each other (Bédouet et al., 
2006). p10, a highly defined matrix protein with a 10 kDa size, 
has specifically demonstrated an induction of ALP expression 
in human fibroblast cell (Zhang et al., 2006), lending greater 
hope that the osteogenic signal molecules can be isolated in 
their vital functional form. A soluble p60 protein conglomerate 
extracted from decalcified nacre possesses sufficient bioactivity 
on MC3T3-E1 and MSCs to induce the secretion of mineral 
nodules (Lao et al., 2007). In another fractionation experiment, 
four proteins were found with homologous sequences to Wnt 
inhibitor factor-1 (WIF-1) and tenascin C, which are both 
involved in bone remodeling (Oliveira et al., 2012). The SPM 
has been found to upregulate osteoblast biomineralization and 
suppress  osteoclast formation during bone remodelling and 
homeostasis. Recently it has been used to successfully repair 
osteoporotic bone in vivo (Kim et al., 2012). 
In this study, we focus on the biochemical theme that has 
dominated nacre osteoinduction studies over more than a decade. 
Furthermore, for the first time, we have tested and evaluated nacre 
osteoinduction potency on primary human osteoprogenitors and 
mesenchymal stromal cells derived from the bone marrow. Our 
findings suggest that nacre based products possess the initial 
potential to “kickstart” bone regeneration from mesenchymal stem 
cell precursors. This evidence shows that the potency of nacre can 
be increased and provide new hope for treatment of patients. 
 
MATERIALS AND METHODS 
 
Materials 
Cell culture media, dexamethasone, ALP kits, and all other 
biochemical reagents were of analytical grade and supplied by 
Sigma-Aldrich (USA) unless otherwise stated. Nacre wafers 
were obtained as offcuts from Gillett & Son (UK). 
 
Production of nacre chips 
Nacre wafers previously sliced away from the shells of Pinctada 
maxima were ground and powdered in a ceramic pestle to 
generate an approximate 500-750 μm dispersion of chip sizes 
using a fine test sieve (pore size 500 μm). These nacre chips 
were used in preference to a fine powder of nacre (< 100 μm), 
as used in some in vivo models, to prevent the removal of 
excessive volumes of deposited nacre during media changes 
on every alternate day. Due to their factory-based source the 
nacre chips were sterilized with bursts of γ-ray radiation at 
2,500 rads every 12 min and ended after 5 h. After washing in 
phosphate buffered saline (PBS), nacre chips were then 
thoroughly washed in antibiotic and anti-mycotic solution 
(Sigma-Aldrich, USA) at a 1× dilution for 24 h to kill any 
bacterial and fungal contaminants present in the nacre just prior 
to cell culture. The chips were then washed 3 times in PBS 
prior to human cell culture. 
 
Primary human cell culture 
Primary cultures of bone marrow cells were established from 
hematologically normal patients undergoing routine total hip 
replacement surgery. Samples were used with approval from the 
Southampton Hospital Ethics Committee (LREC 194/99). Human 
bone marrow cells were isolated as previously described by 
Yang et al. (2003). Bone marrow cells were maintained in 10% α-
MEM at 37°C in a 5% humidified atmosphere. STRO-1+ enriched 
mesenchymal stem cell populations were isolated using the 
protocol as described by Stewart et al. (2003). The STRO-1 
antibody hybridoma was kindly provided by Dr. J Beresford 
(University of Bath, UK). Preparation of STRO-1+ cell fractions 
was carried out as previously described using magnetic assisted 
cell sorting (MACS) (Yang et al., 2003). 
 
C2C12 pro-myoblast cell culture 
Mouse-derived pro-myoblast cells (C2C12) numbering 2 × 106 
were cultured in Dulbecco’s modified Eagle media (DMEM) 
supplemented with 10% FCS in the presence of 0.1 g of nacre 
chips (500-750 μm in size). In addition, C2C12 pro-myoblasts 
were cultured in DMEM containing 100 ng/ml rhBMP-2 to 
confirm the osteogenic conversion of these cells along with no 
treatment controls (n = 6). The cells were cultured for 5 days. 
 
Osteoinduction differentiation assay with nacre chips 
Following trypsinization from the culture flask and re-
suspension in serum-free α-MEM, 4 × 105 C2C12 mouse pro-
myoblast cells were seeded onto 0.25 g of fully sterilized nacre 
chips inside each 6-W-P culture well. The pro-myoblast seeded 
nacre chips were covered with basic media in one set of six 
wells and osteogenic media in another set of six wells. An iden-
tical number of C2C12 pro-myoblast cells were also seeded 
into culture wells without the nacre chips again in basic and 
osteogenic media conditions, representing the control groups (n 
= 6). All treatment and non-treatment groups of C2C12 pro-
myoblast cells were cultured on nacre for 3, 7 and 14 days.  
 
hBMSC viability and biocompatibility with nacre chips 
Live and necrotic osteoprogenitor cells were fluorescently tagged 
using Cell Tracker Green™ (CMFDA) (5-chloromethyl fluorescein 
diacetate) and Ethidium Homodimer-1 (EH-1) for 45 min in the 
incubator. CFMDA fluorescence is metabolically activated inside 
the cytoplasm of viable cells. The green viable cells and the red 
necrotic cells were detected using fluorescence microscopy with a 
Leica DMIRB/E (Leica Microsystems, Germany). 
 
hBMSC growth and differentiation assays with nacre chips 
Primary unselected osteoprogenitor cell populations, numbering 
2 × 106, at passage 1, were seeded onto 0.25 g of nacre chips 
in 12 and 6 tissue culture well plates. Both cell types were 
cultivated for 14 days in basic media (supplemented with 10% 
FCS), osteogenic media (supplemented with 10% FCS, de- 
xamethasone and ascorbate) (n = 6), and media supplemented 
with 100 ng/ml of rhBMP-2 osteogenic growth factor. 
Concurrently, human osteoprogenitor cells were grown without 
nacre chips in basic, osteogenic, and rhBMP-2 infused media, 
representing the control groups (n = 6). Histological detection of 
ALP was performed following fixation in 95% (v/v) ethanol using 
a Sigma ALP kit (Sigma-Aldrich, USA) according to the 
manufacturer’s instructions. ALP enzyme activity was measured 
using p-nitro-phenyl phosphate as the substrate in 2-amino-2-
methyl-1-propanol alkaline buffer solution (1.5 M, pH 10.3 at 
25°C). The DNA content was measured using a PicoGreen 
molecular probe as per manufacturer’s instructions (Molecular 
Probes, USA). The specific activity of osteoprogenitor cells was 
expressed as micro (μ) Moles of p-nitrophenol/h/μg DNA +/-SD.
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Fig. 1. (A) C2C12 pro-myoblast cell 3D pellet co-cultured with nacre particles in basic media and stained for ALP at day 7 (scale bar =15 μm). 
(B) C2C12 pro-myoblast cell 3D pellet cultured in basic media supplemented with 100 ng/ml of rhBMP-2 and stained for ALP at day 7 (scale 
bar = 15 μm). (C) C2C12 pro-myoblast ALP expression in the presence of nacre chips at 14 days (scale bar = 25 μm). (D) Brightfield 
microscope image of human osteoprogenitors co-cultured with nacre chips (red arrow) at 7 days on tissue culture plastic (scale bar = 20 μm). 
(E) Human osteoprogenitor ALP activity with and without nacre at 7 days, in osteogenic and basic media compared with rhBMP-2 treatment 
(hBMSC basic media versus rhBMP-2, p < 0.05; hBMSC basic and osteogenic media with nacre versus HBMSC basic and osteogenic media 
without nacre, p < 0.01). (F) A table showing the variation in patient hBMSC ALP expression within and between Nacre and rhBMP-2 treated 
in vitro culture samples (n = 3). 
 
 
 
All ALP measurements were normalized against nacre alone 
negative control readings. 
 
Soluble matrix extraction from nacre particles (SPM) 
The WSM of nacre seashell was extracted following the EDTA-
based method published by Almeida et al. (2001). This method 
was chosen in preference to a milder chemical-free extraction 
protocol using distilled water (Duplat et al., 2007). The reason 
was that the EDTA method yields organic matrix proteins 
closely bound and associated with calcium carbonate mineral 
where the water soaking method does not. And because of 
this, it yielded 25% more protein content for each extraction 
experiment. In brief, 0.5 g nacre particles were ground into a 
fine powder of particles approximately measuring 200 μm. The 
powder was then completely de-mineralized by soaking in 
20 ml of 1 M EDTA disodium salt dihydrate while being 
continuously stirred for 14 days (Almeida et al., 2001). This 
aged EDTA solution contained SPM proteins dissolved away 
from the mineral framework of the particles. The solution was 
then dialyzed against pyrogen-free Milli-Q water (Millipore, 
USA) for 7 days at room temperature before use. This effectively 
removed all cytotoxic EDTA content. The concentration of 
extracted protein from treated nacre particles was measured 
using a Bradford protein detection assay kit (Bio-Rad Laboratories 
Inc., USA) according to the manufacturer's instructions. A low 
range of SPM concentrations were prepared, using the first 
direct extraction solution as a base. The further dilutions were 
made with pyrogen-free distilled water. 
 
Selected and unselected hBMSC cultivation with  
concentrated SPM or rhBMP-2 
STRO-1+ immunoselected hBMSCs were seeded (2 × 104/ml) 
into culture wells of 6 well plates (n = 6) and covered with FCS 
free media comprising selected concentrations of SPM. The 
SPM concentration series was framed by the maximum yield of 
matrix proteins extracted using the EDTA method (0.2 mg/ml). 
In another osteogenic treatment group, 100 ng/ml of rhBMP-2 
was added to basic culture media with human mesenchymal 
stromal cells (hMSCs). The rhBMP-2 concentration applied was 
previously shown to induce the maximum osteogenic response 
in hBMSCs (Yang et al., 2003). 
 
Assays for measuring osteosecretory activity of selected 
hMSCs with nacre SPM ALP activity 
ALP activity was measured from nacre SPM and non-SPM 
treated selected hMSC populations as previously described. 
 
Sircol colourmetric binding assay for collagens I-IV  
detection 
Nacre SPM treated hBMSC samples were assayed for 
collagens (I-IV) using standard proprietary kits. Samples were 
dispersed in 300 μl of 0.05% Triton, and cells were lysed by 
freeze-thawing three times. The Sircol Collagen Assay Kit 
(Biocolor Ltd., UK) was used to analyze collagen levels. Samples
A B C D
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were run in triplicate and read at 540 nm. Nacre only samples 
did not affect spectrophotometer readings. 
 
ELISA assay for osteocalcin protein detection 
hBMSC samples with and without SPM treatment were assayed for 
osteocalcin, a late marker for bone tissue formation. The samples 
were dispersed in 250 μl of 0.05% Triton, and the cells were lysed by 
freeze-thawing three times. Osteocalcin was measured using the 
Intact Human Osteocalcin ELISA assay Kit according to the 
manufacturer’s instructions (Biomedical Tech-nologies In., USA). 
Samples were run in triplicate and monitored at 540 nm. 
 
Statistical analysis 
Statistical significance was analyzed using the unpaired t-test 
and ANOVA and all results are shown as mean ± SD. Samples 
were run in triplicate for the biochemical assays. Statistical 
analysis was performed using GraphPad Instant Software 
(GraphPad Software Inc., USA). All experiments were repeated 
at least three times. 
 
RESULTS AND DISCUSSION 
 
Nacre osteoinduction differentiation assay with nacre chips 
The C2C12 pro-myoblast cell line is exquisitely and specifically 
sensitive to rhBMP-2 osteogenic stimulation that results in 
differentiation along the osteoblast cell lineage. It has been 
used to test the osteoinductive capability of cells and proteins. 
To determine whether nacre induced a similar phenotypic 
response to rhBMP-2 treatment, C2C12 pro-myoblast cells 
were co-cultured with nacre particles in vitro. The first result 
was that nacre chips were found to induce osteogenic 
differentiation in co-cultured pro-myoblasts as shown by strong 
positive ALP red staining in both traditional 2D (monolayer) and 
tissue-realistic 3D (pellet) cultures. This first occurred on day 2 
(Figs. 1A and 2B). Nacre induced sporadic C2C12 ALP expression 
by day 7. Positive ALP expression of C2C12 pro-myoblasts 
became much more extensive at 14 days reaching 70% of the 
total population of cells in monolayer culture and sphere 
cultures (Fig. 1C). 
 
Unselected primary hBMSC osteogenic responses to nacre 
particles in vitro 
Based on the finding that nacre particles could stimulate 
osteogenesis in pro-myoblasts, at potencies equivalent to 
rhBMP-2 osteoinductive stimulation, we extended the study to 
include primary human bone marrow derived cell populations 
(hBMSCs, BMSCs, skeletal stem cells). These cell types are now 
the foundation of current bone tissue engineering strategies in the 
A B 
DC 
E 
Fig. 2. (A) Dose-dependent action of 
extracted SPM on hBMSC ALP activi-
ty at day 3. (B) Dose-dependent action 
of extracted SPM on hBMSC number 
at day 28. (C) Comparison of ALP 
activity at 24 h between SPM-treated 
(180 μg/ml) immunoselected hMSC 
and hMSCs cultured in osteogenic 
media (p < 0.001, n = 4). (D) Compar-
ison of ALP activity at 21 days be-
tween SPM-treated (180 μg/ml) im-
muneselected hMSC and hMSCs 
cultured in osteogenic media (p < 
0.01, n = 4). (E) Quantitative collagen 
binding assay comparing immouno-
selected hMSCs treated with SPM 
and hMSCs without added SPM (p < 
0.001, n = 4). 
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laboratory context and gradually in clinical trials. Nacre particles 
with a fixed, uniform size range were cultured with unselected 
primary hBMSCs in static culture for up to 14 days (Fig. 1D). ALP 
activity in the presence of nacre chips was significantly increased 
compared to non-nacre controls at day 7 in both basic (10% 
FCS) and ascorbate and dexamethasone supplemented 
osteogenic media (Fig. 1E; p < 0.01). Thus, the nacre chips had 
the same specialization induction effect as osteogenic media. 
Importantly, the measured ALP response of unselected primary 
hBMSCs to osteogenic media and unselected primary hBMSCs 
treated with 100 ng/ml rhBMP-2 (p < 0.05) was significantly lower 
than nacre-treated unselected primary hBMSCs. Thus, hBMSCs 
co-cultured with nacre chips led to a stronger osteoinductive 
biochemical response than when they were treated to the most 
potent factor available for osteoinduction, rhBMP-2. It should be 
noted that these results represent an average of unselected 
primary hBMSCs from 3 different patients and it must be noted 
that there is significant variability between these different 
samples. There are other potential applications where a soluble 
and concentrated SPM product for osteoinduction is preferable.  
 
Effects of nacre SPM on selected primary hMSC and 
unselected primary hBMSC 
The SPM extract from nacre was added to serum-free culture 
media at concentrations varying between 0.008-0.2 mg/ml to 
test the dose-dependency of immuno-selected primary hMSC 
or unselected primary hBMSC populations. The highest con-
centration in this range generated the strongest early 
osteogenic response and so was the quantity used in the main 
experiments. Within 3 days the ALP activity of unselected 
primary hBMSCs was up-regulated when treated with 0.2 
mg/ml of SPM (Fig. 2A). The total cell number increased during 
this similar culture time, but significantly more so in cell 
populations treated with SPM. This response was uniformly 
dose-dependent in unselected hBMSC populations in a range 
of concentrations between 0 and 0.2 mg/ml (Fig. 2B). The 
lowest concentrations of SPM appear to have an effect on 
proliferation only. In 2D monolayer culture immuno-selected 
primary hMSC ALP expression was significantly elevated in the 
presence of 0.18 mg/mL SPM within 24 h (Figs. 2C and 2D; p < 
0.001). However, at 7, 14, and 21 days, unselected hMSC ALP 
expression was significantly lower than the non-SPM treated 
controls. (Fig. 2D; p < 0.05). Significantly, levels of bone associated 
collagens, as quantified by an ELISA assay were up-regulated 
in the SPM samples at 21 days indicating more advanced 
differentiation along the osteoblast lineage than control samples 
(Fig. 2E; p < 0.001). It is noteworthy that, in unselected primary 
hBMSC populations, ALP secretion was absent at 14 days in 
culture indicating either unselected primary hBMSC had de-
differentiated or fully differentiated into bone forming precursor 
cells. Differentiation of unselected primary hBMSC into a 
committed osteoblast phenotype was confirmed at day 7 by 
measured secretion of osteocalcin (3.5 ng/ml +/- 2.9; n = 3). 
Osteocalcin was absent from all other nacre-free samples. The 
sequential pattern of rapid differentiation followed by proliferation 
observed in these nacre-treated samples also occurred in 
unselected primary hBMSC populations cultured in osteogenic 
media containing dexamethasone and ascorbate or rhBMP-2 at 
100 ng/ml (data not shown). 
Nacre is an osteoinductive nature derived biomaterial that 
invokes original new bone production from the beginning by 
activating human osteoblasts It has also sufficient potency to 
recruit and potentiate latent human osteoprogenitors to build new 
native, woven and lamellar bone in the mandible of a single 
human patient (Atlan et al., 1997). However, since that landmark 
human trial, there have been no previous follow-up studies to 
measure the first immediate osteoinductive responses of primary 
human progenitor cells, in cell culture and sourced from fresh 
bone marrow, to nacre chips and nacre SPM. Furthermore there 
are still questions over the osteoinductive authenticity of nacre. 
Since these cell types are now vital elements in tissue 
engineering of therapeutic bone replacements, it is important to 
test the osteoinductive responses of cell types with strong clinical 
relevance. We demonstrated in this study that nacre and its 
organic matrix directs the fate of co-cultured osteoprogenitor 
cells towards the osteoblast phenotype. We confirmed previous 
published results that the soluble protein-enriched and de-
mineralized organic matrix of nacre is one of the most probable 
sources for this induction, although, we must not exclude the 
potential osteoinductive effects of the mineral structure on 
anchoring progenitors, which was highlighted in the nacre 
particle experiments. The fact that nacre chips can elicit such 
osteoinductive responses more potent than rhBMP-2 addition is 
very significant and also hints at nacre structure playing a role 
in the induction of cell differentiation. The use of nacre chips 
and organic matrix extracts typify the potency of nacre induced 
osteogenic differentiation of uncommitted and pre-committed 
precursors and raises expectation for a new accessible and 
abundant pre-made alternative to rhBMP-2. Nacre could potentially 
serve a role in therapeutic strategies for engineering clinically 
relevant original bone from the beginning with osteogenic 
precursor cells. 
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